Chemoinformaics analysis of Vetiveryl acetate
| Molecular Weight | 262.393 | nRot | 1 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 13 |
| Exact Molecular Weight | 262.193 | nRing | 2 |
| Solubility: LogS | -4.639 | nHRing | 0 |
| Solubility: LogP | 4.45 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 47.3306 |
| nHD | 0 | BPOL | 28.6874 |
| QED | 0.521 |
| Synth | 4.421 |
| Natural Product Likeliness | 2.368 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.028 |
| Pgp-sub | 0.013 |
| HIA | 0.037 |
| CACO-2 | -4.466 |
| MDCK | 0.0000198 |
| BBB | 0.654 |
| PPB | 0.971938 |
| VDSS | 3.603 |
| FU | 0.0381888 |
| CYP1A2-inh | 0.183 |
| CYP1A2-sub | 0.157 |
| CYP2c19-inh | 0.12 |
| CYP2c19-sub | 0.905 |
| CYP2c9-inh | 0.512 |
| CYP2c9-sub | 0.547 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.21 |
| CYP3a4-inh | 0.409 |
| CYP3a4-sub | 0.441 |
| CL | 11.26 |
| T12 | 0.119 |
| hERG | 0.009 |
| Ames | 0.021 |
| ROA | 0.018 |
| SkinSen | 0.043 |
| Carcinogencity | 0.077 |
| EI | 0.106 |
| Respiratory | 0.03 |
| NR-Aromatase | 0.002 |
| Antiviral | Yes |
| Prediction | 0.794971 |